Literature DB >> 26529968

[A Study to Determine the Optimum Antigens for the Serodiagnosis of Helicobacter Pylori Infection in Japanese Patients and the Association with IgG Subclass and Gastric Cancer].

Masahide Kita, Susumu Take, Hiroyuki Okada, Osamu Matsushita, Kenji Yokota.   

Abstract

Atrophic gastritis is caused by Helicobacter pylori infection, and is involved in gastric cancer. In this study, we investigated the association with total IgG and IgG subclass antibodies using several strains isolated from Japanese in H. pylori positive and negative individuals, and gastric atrophy using measuring pepsinogen I and II levels. We found that total IgG antibody measurement using typical Japanese genotype as an antigen was available for diagnosis of H. pylori infection, whereas IgG1 and IgG2 antibodies were not for diagnosis. Furthermore, the IgG1/G2 ratio was elevated in a patient with gastric cancer. The accuracy of serodiagnosis of H. pylori infection may increase when the optimal antigens are used, and measurement IgG subclass may provide additional prediction of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26529968

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  3 in total

1.  Factors for Negative Result in Serum Anti-Helicobacter pylori IgG Antibody Test in Adult Subjects With Nodular Gastritis: A Single-center Study.

Authors:  Kyoichi Adachi; Kanako Kishi; Utae Sakamoto; Tomoko Mishiro; Eiko Okimoto; Norihisa Ishimura; Shunji Ishihara
Journal:  Cureus       Date:  2021-06-14

2.  Analysis of negative result in serum anti-H. pylori IgG antibody test in cases with gastric mucosal atrophy.

Authors:  Kyoichi Adachi; Tomoko Mishiro; Shino Tanaka; Yoshikazu Kinoshita
Journal:  J Clin Biochem Nutr       Date:  2016-06-10       Impact factor: 3.114

3.  Serodiagnosis and Bacterial Genome of Helicobacter pylori Infection.

Authors:  Aina Ichihara; Hinako Ojima; Kazuyoshi Gotoh; Osamu Matsushita; Susumu Take; Hiroyuki Okada; Akari Watanabe; Kenji Yokota
Journal:  Toxins (Basel)       Date:  2021-07-05       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.